Controversies in the Management of the Anemia of Prematurity Using Single-Donor Red Blood Cell Transfusions and/or Recombinant Human Erythropoietin
To access this article, please choose from the options below
This study was supported by grants P01 HL46925 and RR 00059 from the National Institutes of Health, Bethesda, Md.
PII: S0887-7963(05)00080-5
doi:10.1016/j.tmrv.2005.08.003
© 2006 Elsevier Inc. All rights reserved.
